- Home
- SOPA vs ENSC Comparison
SOPA vs ENSC Comparison
Compare SOPA & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPA
- ENSC
- Stock Information
- Founded
- SOPA 2018
- ENSC 2003
- Country
- SOPA Singapore
- ENSC United States
- Employees
- SOPA N/A
- ENSC N/A
- Industry
- SOPA EDP Services
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- SOPA Technology
- ENSC Health Care
- Exchange
- SOPA Nasdaq
- ENSC Nasdaq
- Market Cap
- SOPA 3.8M
- ENSC 2.9M
- IPO Year
- SOPA 2021
- ENSC N/A
- Fundamental
- Price
- SOPA $0.87
- ENSC $2.93
- Analyst Decision
- SOPA Strong Buy
- ENSC
- Analyst Count
- SOPA 1
- ENSC 0
- Target Price
- SOPA $14.00
- ENSC N/A
- AVG Volume (30 Days)
- SOPA 104.4K
- ENSC 4.9M
- Earning Date
- SOPA 05-14-2025
- ENSC 05-12-2025
- Dividend Yield
- SOPA N/A
- ENSC N/A
- EPS Growth
- SOPA N/A
- ENSC N/A
- EPS
- SOPA N/A
- ENSC N/A
- Revenue
- SOPA $7,105,530.00
- ENSC $5,210,031.00
- Revenue This Year
- SOPA $43.55
- ENSC N/A
- Revenue Next Year
- SOPA N/A
- ENSC N/A
- P/E Ratio
- SOPA N/A
- ENSC N/A
- Revenue Growth
- SOPA N/A
- ENSC 133.58
- 52 Week Low
- SOPA $0.65
- ENSC $1.62
- 52 Week High
- SOPA $6.75
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- SOPA 46.63
- ENSC 50.85
- Support Level
- SOPA $0.66
- ENSC $3.02
- Resistance Level
- SOPA $0.94
- ENSC $3.49
- Average True Range (ATR)
- SOPA 0.08
- ENSC 0.40
- MACD
- SOPA 0.05
- ENSC 0.25
- Stochastic Oscillator
- SOPA 76.01
- ENSC 40.56
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.